Analyses of Cost Data in Economic Evaluations Conducted Alongside Randomized Controlled Trials
Authors:
- Jalpa A. DoshiJDJalpa A. Doshi
- Henry A. GlickHGHenry A. Glick
- Daniel PolskyDPDaniel Polsky
- 1 September 2006
- journal article
- review article
- Published by Elsevier in Value in Health
- Vol. 9 (5) , 334-340
Abstract
No abstract availableKeywords
This publication has 31 references indexed in Scilit:
- Good Research Practices for Cost-Effectiveness Analysis Alongside Clinical Trials: The ISPOR RCT-CEA Task Force ReportValue in Health, 2005
- Analysis and interpretation of cost data in randomised controlled trials: review of published studiesBMJ, 1998
- Carrier Screening for Cystic FibrosisMedical Decision Making, 1998
- Confidence Intervals for Cost-Effectiveness Ratios: A Comparison of Four MethodsHealth Economics, 1997
- Guidelines for authors and peer reviewers of economic submissions to the BMJBMJ, 1996
- ESTIMATING CONFIDENCE INTERVALS FOR COST-EFFECTIVENESS RATIOS: AN EXAMPLE FROM A RANDOMIZED TRIALStatistics in Medicine, 1996
- Confidence intervals for cost-effectiveness ratios: An application of Fieller's theoremHealth Economics, 1996
- Costs, effects and C/E‐ratios alongside a clinical trialHealth Economics, 1994
- In Search of Power and Significance: Issues in the Design and Analysis of Stochastic Cost-Effectiveness Studies in Health CareMedical Care, 1994
- Costs and cost-minimisation analysis.BMJ, 1993